Wedell-Wedellsborg Johan — SEC Form 4 filings

SEC reporting owner CIK 1753185. 3 Form 4 filings on record with FilingPulse; latest filed 2025-09-18.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-06-13 to 2025-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Y-mAbs Therapeutics, Inc. (YMAB)Director, 10% owner316

Form 4 filings — Wedell-Wedellsborg Johan

FiledFormIssuerReported transactionsSource
2025-09-184Y-mAbs Therapeutics, Inc. (YMAB)Code (U): 5,825 @ $8.60 · Disposition to issuer (D): 25,080 · Code (U): 4,559,233 @ $8.60 · Disposition to issuer (D): 36,000 (derivative) · Disposition to issuer (D): 32,000 (derivative) · Disposition to issuer (D): 16,000 (derivative) · +6 moreEDGAR
2025-07-024Y-mAbs Therapeutics, Inc. (YMAB)Grant/award (A): 25,080 @ $0 · Grant/award (A): 33,450 (derivative) @ $0EDGAR
2024-06-134Y-mAbs Therapeutics, Inc. (YMAB)Grant/award (A): 3,495 @ $0 · Grant/award (A): 14,545 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1753185 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →